Pseudomonas-dominant Microbiome Elicits Sustained IL-1β Upregulation in Alveolar Macrophages from Lung Transplant Recipients.

[1]  M. Myerburg,et al.  Rate of recipient‐derived alveolar macrophage development and major histocompatibility complex cross‐decoration after lung transplantation in humans , 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  R. Vos,et al.  Pseudomonas aeruginosa and chronic lung allograft dysfunction: does evading an iceberg prevent the ship from sinking? , 2021, European Respiratory Journal.

[3]  L. Påhlman,et al.  Divergent airway microbiomes in lung transplant recipients with or without pulmonary infection , 2021, Respiratory Research.

[4]  R. Gibson,et al.  Inflammasome Genetic Variants, Macrophage Function, and Clinical Outcomes in Cystic Fibrosis. , 2021, American journal of respiratory cell and molecular biology.

[5]  J. Erb-Downward,et al.  Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study. , 2021, The Lancet. Respiratory medicine.

[6]  A. Koutsokera,et al.  A prevalent and culturable microbiota links ecological balance to clinical stability of the human lung after transplantation , 2020, Nature Communications.

[7]  Joyce S Lee,et al.  Type‐1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  E. El-Omar,et al.  The role of the microbiome and the NLRP3 inflammasome in the gut and lung , 2020, Journal of leukocyte biology.

[9]  R. Collman,et al.  4167 Peri-transplant Lung Microbiome Reveal Oral Bacteria, Pepsin And Inflammatory Markers Co-associate With Primary Graft Dysfunction, Implicating Aspiration As A Potential Contributor , 2020, Journal of Clinical and Translational Science.

[10]  J. Greenland,et al.  Transcriptome Analysis of Airway Brushes in Lung Transplant Recipients with and without Chronic Lung Allograft Dysfunction. , 2020, The Journal of Heart and Lung Transplantation.

[11]  D. Kreisel,et al.  Pseudomonas aeruginosa and acute rejection independently increase the risk of donor‐specific antibodies after lung transplantation , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  T. Willinger,et al.  Origin and ontogeny of lung macrophages: from mice to humans , 2019, Immunology.

[13]  Erik L. Clarke,et al.  Upper Respiratory Dysbiosis with a Facultative-Dominated Ecotype in Advanced Lung Disease and Dynamic Change after Lung Transplant. , 2019, Annals of the American Thoracic Society.

[14]  B. Meiser,et al.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  A. Shilatifard,et al.  Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis , 2019, American journal of respiratory and critical care medicine.

[16]  G. Verleden,et al.  Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  J. Pilewski,et al.  Airway Transcriptome Analysis and Immune Proteome Profiling of the Lung Allograft Reveals Novel Immune Signatures in Chronic Lung Allograft Dysfunction , 2019, The Journal of Heart and Lung Transplantation.

[18]  S. Quake,et al.  Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation , 2019, EBioMedicine.

[19]  S. Cuzzocrea,et al.  INVOLVEMENT OF TLR4 AND PPAR‐α RECEPTORS IN HOST RESPONSE AND NLRP3 INFLAMMOSOME ACTIVATION, AGAINST PULMONARY INFECTION WITH PSEUDOMOSAS AERUGINOSA , 2018, Shock.

[20]  Ahmed A. Metwally,et al.  Bronchiolitis obliterans syndrome susceptibility and the pulmonary microbiome. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[21]  Hong Wang,et al.  Pseudomonas aeruginosa infection alters the macrophage phenotype switching process during wound healing in diabetic mice , 2018, Cell biology international.

[22]  Masahiro Yamamoto,et al.  Guanylate binding proteins facilitate caspase-11-dependent pyroptosis in response to type 3 secretion system-negative Pseudomonas aeruginosa , 2018, Cell Death Discovery.

[23]  J. Nagendran,et al.  Baseline lung allograft dysfunction is associated with impaired survival after double-lung transplantation. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  R. Knight,et al.  Improving saliva shotgun metagenomics by chemical host DNA depletion , 2018, Microbiome.

[25]  Erik L. Clarke,et al.  Microbial Lineages in Sarcoidosis. A Metagenomic Analysis Tailored for Low‐Microbial Content Samples , 2018, American journal of respiratory and critical care medicine.

[26]  C. Auffray,et al.  Airway microbiota signals anabolic and catabolic remodeling in the transplanted lung , 2017, The Journal of allergy and clinical immunology.

[27]  Kimberly A. Thomas,et al.  Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation , 2017, Front. Med..

[28]  R. Elashoff,et al.  Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  C. Benden,et al.  Airway Microbiota Determines Innate Cell Inflammatory or Tissue Remodeling Profiles in Lung Transplantation. , 2016, American journal of respiratory and critical care medicine.

[30]  W. Mitzner,et al.  Translational Research in Acute Lung Injury and Pulmonary Fibrosis Enhanced resolution of experimental ARDS through IL-4-mediated lung macrophage reprogramming , 2016 .

[31]  V. Napolioni,et al.  IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis , 2016, Nature Communications.

[32]  P. Corris,et al.  Pseudomonas aeruginosa Induced Airway Epithelial Injury Drives Fibroblast Activation: A Mechanism in Chronic Lung Allograft Dysfunction , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[33]  M. Sayan,et al.  The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases , 2015, Particle and Fibre Toxicology.

[34]  F. Geissmann,et al.  The development and maintenance of resident macrophages , 2015, Nature Immunology.

[35]  P. Gibson,et al.  Inflammasomes in COPD and neutrophilic asthma , 2015, Thorax.

[36]  G. Huffnagle,et al.  The bacterial microbiota in inflammatory lung diseases. , 2015, Clinical immunology.

[37]  Jeffrey L. Curtis,et al.  Changes in the Lung Microbiome following Lung Transplantation Include the Emergence of Two Distinct Pseudomonas Species with Distinct Clinical Associations , 2014, PloS one.

[38]  L. King,et al.  Diverse macrophage populations mediate acute lung inflammation and resolution. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[39]  Joshua N. Daly,et al.  Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome. , 2013, American journal of respiratory and critical care medicine.

[40]  Kyle Bittinger,et al.  Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. , 2012, American journal of respiratory and critical care medicine.

[41]  Emily S. Charlson,et al.  Assessing Bacterial Populations in the Lung by Replicate Analysis of Samples from the Upper and Lower Respiratory Tracts , 2012, PloS one.

[42]  B. Koller,et al.  NLRP1-Dependent Pyroptosis Leads to Acute Lung Injury and Morbidity in Mice , 2012, The Journal of Immunology.

[43]  I. Adcock,et al.  Inflammasome signaling in pathogenesis of lung diseases. , 2012, Current pharmaceutical design.

[44]  M. Birrell,et al.  The role of the NLRP3 inflammasome in the pathogenesis of airway disease. , 2011, Pharmacology & therapeutics.

[45]  J. Belperio,et al.  Lung transplantation: infection, inflammation, and the microbiome , 2011, Seminars in Immunopathology.

[46]  Marc Daigneault,et al.  The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived Macrophages , 2010, PloS one.

[47]  K. Kelly,et al.  Inflammasomes bridge signaling between pathogen identification and the immune response. , 2009, Drugs of today.

[48]  A. Bharat,et al.  Immunological link between primary graft dysfunction and chronic lung allograft rejection. , 2008, The Annals of thoracic surgery.

[49]  G. Verleden,et al.  Pseudomonal airway colonisation: risk factor for bronchiolitis obliterans syndrome after lung transplantation? , 2008, European Respiratory Journal.

[50]  P. Corris,et al.  Pseudomonas aeruginosa Colonization of the Allograft After Lung Transplantation and the Risk of Bronchiolitis Obliterans Syndrome , 2008, Transplantation.

[51]  A. Bharat,et al.  Early Posttransplant Inflammation Promotes the Development of Alloimmunity and Chronic Human Lung Allograft Rejection , 2007, Transplantation.